Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients With Head and Neck Cancer: Results of the Biology-Driven Phase 2 Clinical Trial Pravacur.
Bourgier C., Auperin A., Rivera S., Boisselier P., Petit B., Lang P., Lassau N., Taourel P., Tetreau R., Azria D. et al., 2019/06/01. International journal of radiation oncology, biology, physics, 104 (2) pp. 365-373. Peer-reviewed.
ici le détail